Vital Access Corp Announces FDA Clearance Of VWING™ Vascular Needle Guide

Vital Access Corp. has received U.S. FDA market clearance for its patented VWING™ Vascular Needle Guide which has been shown to enable vascular access to arteriovenous fistulas for patients undergoing hemodialysis.

Vital Access Corp Announces FDA Clearance Of VWING™ Vascular Needle Guide (via PR Newswire)

SALT LAKE CITY, Sept. 16, 2013 /PRNewswire/ — Vital Access Corp. today announced that it has received U.S. Food and Drug Administration (FDA) market clearance for its patented VWING™ Vascular Needle Guide which has been shown to enable vascular access…

published: September 17, 2013 in: Approval/Clearance, Vascular

Most read

Latest

^